Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

REVISED DOUBLE ANTIBODY AMPHETAMINE

K-Number: K882228 · 1988-08-08

ApplicantDiagnostic Products Corp.
Decision Date1988-08-08
Product CodeDJP
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

REVISED DOUBLE ANTIBODY AMPHETAMINE is the device name listed in this FDA 510(k) record. The listed applicant is Diagnostic Products Corp.. It received FDA 510(k) clearance on 1988-08-08 under 510(k) number K882228. The device is classified under product code DJP. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the REVISED DOUBLE ANTIBODY AMPHETAMINE?

REVISED DOUBLE ANTIBODY AMPHETAMINE is a medical device that received FDA 510(k) clearance on 1988-08-08. The listed applicant is Diagnostic Products Corp.. The 510(k) number is K882228.

When did REVISED DOUBLE ANTIBODY AMPHETAMINE receive FDA 510(k) clearance?

REVISED DOUBLE ANTIBODY AMPHETAMINE received FDA 510(k) clearance on 1988-08-08, under 510(k) number K882228.

Who is the listed applicant for REVISED DOUBLE ANTIBODY AMPHETAMINE?

The FDA 510(k) record lists Diagnostic Products Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for REVISED DOUBLE ANTIBODY AMPHETAMINE?

The FDA product code for REVISED DOUBLE ANTIBODY AMPHETAMINE is DJP.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Diagnostic Products Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K063045IMMULITE 2000, IMMULITE 2500 VANCOMYCINK034055IMMULITE 2500 CK-MB, 2500 MYOGLOBIN, 2500 STAT TROPONIN IK033234IMMULITE 2500 AUTOMATED IMMUNOASSAY ANALYZERK032881IMMULITE/IMMULITE 1000 TOTAL TESTOSTERONE AND IMMULITE 2000 TOTAL TESTOSTERONEK023152IMMULITE 2000 ALLERGEN-SPECIFIC IGEK023304IMMULITE/IMMULITE 1000 CALCITONIN, MODEL LKCL AND IMMULITE 2000 CALCITONIN, MODEL L2KCL

View all 321 devices →

Related Devices (Code: DJP)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K960526PRIMIDONE EIA TESTDiagnostic Reagents, Inc.K913866URINE AMPHETAMINE DIRECT RIA KIT (I-125)Immunalysis CorporationK912755ABUSCREEN RADIOIMMUNOASSAY FOR AMPHETAMINERoche Diagnostic Systems, Inc.K881817ABUSCREEN(R) ONTRAK(TM) FOR AMPHETAMINESRoche Diagnostic Systems, Inc.K854009ABUSCREEN RADIOIMMUNOASSAY FOR AMPHETAMINE-HIGH SPRoche Diagnostic Systems, Inc.K830482ABUSCREEN RADIOIMMUNOASSAY-AMPHETAMINEHoffmann-La Roche, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑